XML 34 R19.htm IDEA: XBRL DOCUMENT v3.21.2
Restatement of Previously Issued Financial Statements (Tables)
4 Months Ended
Dec. 31, 2020
Restatement of Previously Issued Financial Statements  
Summary of impact of the restatement on the balance sheets, statements of operations and statements of cash flows

    

As of December 31, 2020

As Previously

Restatement

    

Reported

    

Adjustment

    

As Restated

Balance Sheet

  

 

  

 

  

Total assets

$

347,610,494

$

$

347,610,494

Liabilities and Stockholders’ Equity:

 

  

 

  

 

  

Total current liabilities

$

985,396

$

$

985,396

Deferred underwriting commissions

 

12,075,000

 

 

12,075,000

Stock warrant liabilities

 

 

42,283,500

 

42,283,500

Total liabilities

 

13,060,396

 

42,283,500

 

55,343,896

Class A common stock, $0.0001 par value; shares subject to possible redemption

 

329,550,090

 

(42,283,500)

 

287,266,590

Stockholders’ equity

 

  

 

  

 

  

Preferred stock- $0.0001 par value

 

 

 

Class A common stock – $0.0001 par value

 

154

 

423

 

577

Class B common stock – $0.0001 par value

 

863

 

 

863

Additional paid-in-capital

 

5,698,473

 

17,131,409

 

22,829,882

Accumulated deficit

 

(699,482)

 

(17,131,832)

 

(17,831,314.00)

Total stockholders’ equity

 

5,000,008

 

 

5,000,008

Total liabilities and stockholders’ equity

$

347,610,494

$

$

347,610,494

    

Period From August 17, 2020 (inception)

Through December 31, 2020

As Previously

Restatement

    

Reported

    

Adjustment

    

As Restated

Statement of Operations

 

  

 

  

 

  

Loss from operations

$

(709,798)

$

$

(709,798)

Other (expense) income:

 

  

 

  

 

  

Change in fair value of warrant liabilities

 

 

(16,168,500)

 

(16,168,500)

Transaction costs – Warrants

 

 

(963,332)

 

(963,332)

Net gain from investments held in Trust Account

 

10,316

 

 

10,316

Total other (expense) income

 

10,316

 

(17,131,832)

 

(17,121,516)

Loss before income tax expense

 

(699,482)

 

(17,131,832)

 

(17,831,314)

Income tax expense

 

 

 

Net loss

$

(699,482)

$

(17,131,832)

$

(17,831,314)

Basic and Diluted weighted-average Class A common shares outstanding

 

34,500,000

 

 

34,500,000

Basic and Diluted net loss per Class A common shares

$

 

$

Basic and Diluted weighted-average Class B common shares outstanding

 

7,764,706

 

 

7,764,706

Basic and Diluted net loss per Class B common shares

$

(0.09)

$

(2.21)

$

(2.30)

Period From August 17, 2020 (inception)

    

Through December 31, 2020

As Previously

Restatement

    

Reported

    

Adjustment

    

As Restated

Statement of Cash Flows

 

  

 

  

 

  

Net loss

$

(699,482)

$

(17,131,832)

$

(17,831,314)

Change in fair value of warrant liabilities

 

 

(16,168,500)

 

(16,168,500)

Transaction costs – warrants

 

 

(963,332)

 

(963,332)

Net cash used in operating activities

 

(1,958,317)

 

 

(1,958,317)

Net cash used in investing activities

 

(345,000,000)

 

 

(345,000,000)

Net cash provided by financing activities

 

347,673,897

 

 

347,673,897

Net change in cash

$

715,580

$

$

715,580